AFAIK RAC isn't going to test bisantrene on prostate cancer.
If you mean the risk that bisantrene might worsen the disease in say breast cancer, that's extremely low because of the historical trials and the preclinicals.
- Forums
- ASX - By Stock
- Pillar 1 - FTO (new thread)
AFAIK RAC isn't going to test bisantrene on prostate...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.41 |
Change
-0.055(3.77%) |
Mkt cap ! $236.2M |
Open | High | Low | Value | Volume |
$1.45 | $1.45 | $1.40 | $157.9K | 111.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3980 | $1.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.41 | 2613 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3980 | 1.400 |
1 | 3440 | 1.395 |
1 | 2500 | 1.380 |
2 | 1100 | 1.360 |
1 | 1534 | 1.350 |
Price($) | Vol. | No. |
---|---|---|
1.410 | 2613 | 2 |
1.440 | 24 | 1 |
1.445 | 319 | 2 |
1.450 | 699 | 2 |
1.455 | 24 | 1 |
Last trade - 16.10pm 28/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.40 |
  |
Change
-0.055 ( 2.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.44 | $1.40 | 6146 | ||
Last updated 15.46pm 28/05/2024 ? |
Featured News
RAC (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online